Shinnosuke Takemoto

517 total citations
50 papers, 217 citations indexed

About

Shinnosuke Takemoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shinnosuke Takemoto has authored 50 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Shinnosuke Takemoto's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Shinnosuke Takemoto is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Shinnosuke Takemoto collaborates with scholars based in Japan, United States and France. Shinnosuke Takemoto's co-authors include Hiroshi Mukae, Terasaki Pi, Gjertson Dw, Minoru Fukuda, Hiroyuki Yamaguchi, Paul I. Terasaki, Ronald W. Busuttil, Hidenori Koyama, Takaya Ikeda and Katsumi Nakatomi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Shinnosuke Takemoto

44 papers receiving 212 citations

Peers

Shinnosuke Takemoto
Elisabeth A. Kastelijn Netherlands
Paola Incollingo Italy
J. Wohlschläger Germany
Priya Deshpande United States
A Guillemin France
Gunnar Söderdahl Sweden
Stephen Harnicar United States
Martin Koch Germany
M Riggi France
Woo-Kun Kim South Korea
Elisabeth A. Kastelijn Netherlands
Shinnosuke Takemoto
Citations per year, relative to Shinnosuke Takemoto Shinnosuke Takemoto (= 1×) peers Elisabeth A. Kastelijn

Countries citing papers authored by Shinnosuke Takemoto

Since Specialization
Citations

This map shows the geographic impact of Shinnosuke Takemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinnosuke Takemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinnosuke Takemoto more than expected).

Fields of papers citing papers by Shinnosuke Takemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinnosuke Takemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinnosuke Takemoto. The network helps show where Shinnosuke Takemoto may publish in the future.

Co-authorship network of co-authors of Shinnosuke Takemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shinnosuke Takemoto. A scholar is included among the top collaborators of Shinnosuke Takemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinnosuke Takemoto. Shinnosuke Takemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sakamoto, Noriho, Takashi Kido, Hiroshi Ishimoto, et al.. (2025). Antifibrotic effects of IL-12-treated natural killer cells on collagen type I regulation in lung fibroblasts. Experimental Cell Research. 449(1). 114584–114584. 2 indexed citations
3.
Sakamoto, Noriho, Hideki Hayashi, Tsutomu Fukuda, et al.. (2025). Lamellarin D Acts as an Inhibitor of Type I Collagen Production. ChemMedChem. 20(9). e202401001–e202401001. 1 indexed citations
4.
5.
Iwanaga, Naoki, Yuya Ito, Tatsuro Hirayama, et al.. (2024). Neglected Pulmonary Infection Caused by Exophiala dermatitidis Misidentified as Rhodotorula spp.. Mycoses. 67(10). e13804–e13804. 1 indexed citations
6.
Ishimoto, Hiroshi, Noriho Sakamoto, Ritsuko Miyashita, et al.. (2024). Novel method of attaching a suction tube externally to a tracheal tube as an insertion route for a Fogarty catheter in cryobiopsy: Retrospective comparative study. Respiratory Investigation. 62(4). 732–737.
7.
Takazono, Takahiro, Shin‐ya Kawashiri, Yuya Ito, et al.. (2024). Risk factor of non-tuberculous Mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter retrospective study. Respiratory Investigation. 62(3). 322–327. 1 indexed citations
8.
9.
Ishimoto, Hiroshi, Noriho Sakamoto, Takashi Kido, et al.. (2023). Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature. BMC Pulmonary Medicine. 23(1). 289–289. 4 indexed citations
10.
Iwanaga, Naoki, Yuya Ito, Nobuyuki Ashizawa, et al.. (2023). Pulmonary phaeohyphomycosis due to Exophiala dermatitidis in a patient with pulmonary non-tuberculous mycobacterial infection. Journal of Infection and Chemotherapy. 29(6). 615–619. 4 indexed citations
11.
Tanimura, Keiko, Junji Uchino, Hideharu Kimura, et al.. (2023). Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial. The Oncologist. 28(6). 551–e454. 6 indexed citations
12.
Sakamoto, Noriho, Ritsuko Miyashita, Takashi Kido, et al.. (2023). Pulmonary Langerhans cell histiocytosis diagnosed using transbronchial lung cryobiopsy: A case report. Respiratory Medicine Case Reports. 46. 101928–101928.
13.
Takao, Daisuke, Takahiro Takazono, Yuya Ito, et al.. (2023). A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension. Journal of Infection and Chemotherapy. 29(8). 806–808. 3 indexed citations
14.
Soda, Hiroshi, Masataka Yoshida, Shota Nakashima, et al.. (2023). Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia‐inducible factor‐1α, vascular endothelial growth factor, and hypervascularization. Thoracic Cancer. 14(14). 1320–1324. 2 indexed citations
15.
Taniguchi, Hirokazu, Ichiro Sekine, Shinnosuke Takemoto, et al.. (2023). TIM ‐3 expression induces resistance to PD ‐1 inhibitor in G‐CSF ‐producing lung spindle cell carcinoma: A case report. Thoracic Cancer. 14(36). 3556–3560. 1 indexed citations
16.
Taniguchi, Hirokazu, Shinnosuke Takemoto, Hiroyuki Yamaguchi, et al.. (2023). Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma. Frontiers in Immunology. 14. 1058838–1058838. 3 indexed citations
17.
Taniguchi, Hirokazu, Tadaaki Yamada, Shinnosuke Takemoto, et al.. (2022). Pan‐HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK‐rearranged lung cancer. Cancer Science. 114(1). 164–173. 8 indexed citations
18.
Takemoto, Shinnosuke, Minoru Fukuda, Hiroyuki Yamaguchi, et al.. (2019). Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. Thoracic Cancer. 11(2). 389–393. 3 indexed citations
19.
Fukuda, Minoru, Yoshihiro Ohue, Shinnosuke Takemoto, et al.. (2015). Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4. Supportive Care in Cancer. 24(2). 615–619. 16 indexed citations
20.
Fukuda, Minoru, Yoichi Nakamura, Katsumi Nakatomi, et al.. (2014). Life-threatening toxicity in a patient with UGT1A1*6 heterozygous polymorphism after irinotecan-based chemotherapy: a case report. Acta medica Nagasakiensia. 59(2). 63–65. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth A. Kastelijn Breakdown of academic impact, for papers by Paola Incollingo Breakdown of academic impact, for papers by J. Wohlschläger Breakdown of academic impact, for papers by Priya Deshpande Breakdown of academic impact, for papers by A Guillemin Breakdown of academic impact, for papers by Gunnar Söderdahl Breakdown of academic impact, for papers by Stephen Harnicar Breakdown of academic impact, for papers by Martin Koch Breakdown of academic impact, for papers by M Riggi Breakdown of academic impact, for papers by Woo-Kun Kim
Rankless by CCL
2026